Abstract:Ulcerative colitis (UC) is a chronic idiopathic inflammatory condition affecting the rectum and colon. Inflammation and compromisation of the intestinal mucosal barrier are key in UC pathogenesis. Resveratrol (Res) is a naturally occurring polyphenol that exhibits anti‐inflammatory and antioxidant properties. Nuclear factor erythroid‐2‐related factor 2/heme oxygenase 1 (Nrf2/HO‐1) pathway regulates occurrence and development of numerous types of diseases through anti‐inflammatory and antioxidant activity. However, it is not clear whether Nrf2/HO‐1 pathway is involved in the treatment of Res in UC. Therefore, the present study aimed to investigate whether Res modulates the Nrf2/HO‐1 signaling pathway to attenuate UC in mice. Dextran sulfate sodium (DSS) was used to induce experimental UC in male C57BL/6J mice. Disease activity index (DAI) and hematoxylin eosin (H&E) staning was used to assessed the magnitude of colonic lesions in UC mice. ELISA) was utilized to quantify inflammatory cytokines (IL‐6, IL‐1β, TNF‐α and IL‐10) in serum and colon tissues. Immunohistochemistry and Western blot were used to evaluate the expression levels of tight junction (TJ) proteins [zonula occludens (ZO)‐1 and Occludin] in colon tissues. Pharmacokinetic (PK) parameters of Res were derived from TCMSP database. Networkpharmacology was employed to identify the biological function and pharmacological mechanism of Res in the process of relieving UC, and the key target was screened. The binding ability of Res and key target was verified by molecular docking. Finally, the effectiveness of key target was substantiated by Western blot. Res decreased DAI, ameliorated histopathological changes such as crypt loss, disappeatance of the mucosal epithelium, and inflammatory infiltration in mice. Additionally, Res decreased expression of pro‐inflammatory cytokines IL‐6, IL‐1β and TNF‐α and increased anti‐inflammatory factor IL‐10 expression. Res also restored the decreased protein expression of ZO‐1 and occludin after DSS treatment, increasing the integrity of the intestinal mucosal barrier. The PK properties of Res suggested that Res possesses the therapeutic potential for oral administration. Network pharmacology revealed that Res alleviated UC through anti‐inflammatory and antioxidant pathways, and confirmed that Nrf2 has a high binding affinity with Res and is a key target of Res against UC. Western blotting demonstrated that Res treatment increased the protein levels of Nrf2 and HO‐1. In conclusion, Res treatment activated the Nrf2/HO‐1 pathway to decrease clinical symptoms, inflammatory responses, and intestinal mucosal barrier damage in experimental UC mice.

Anti-oxidant Effects of Resveratrol on Mice with DSS-induced Ulcerative Colitis

Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis

Resveratrol ameliorates DSS-induced ulcerative colitis by acting on mouse gut microbiota

[Effects of Resveratrol on Ulcerative Colitis in Mice and Its Mechanism].

Dietary resveratrol attenuated colitis and modulated gut microbiota in dextran sulfate sodium-treated mice.

Distinctive Anti-Inflammatory Effects of Resveratrol, Dihydroresveratrol, and 3-(4-hydroxyphenyl)-propionic Acid on DSS-induced Colitis in Pseudo-Germ-free Mice.

Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1.

Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis

Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO‐1 pathway activity: Integrating animal experiments and network pharmacology

Preventive effects of TLR2 monoclonal antibodies and TLR4 monoclonal antibodies on the colonal mucosal inflammatory cytokines (IFN-γ,IL-4 and IL-17) expression in mice with DSS-induced acute ulcerative colitis

Role of Micrornas in Resveratrol-Mediated Mitigation of Colitis-Associated Tumorigenesis in Apc(Min/+) Mice

Plant Polyphenols Attenuate DSS-induced Ulcerative Colitis in Mice via Antioxidation, Anti-inflammation and Microbiota Regulation

Rosa Roxburghii Tratt Fruit Extract Prevents Dss-Induced Ulcerative Colitis in Mice by Modulating the Gut Microbiota and the IL-17 Signaling Pathway

Effect of chitosan on dextran sulfate sodium sulfate-induced ulcerative colitis in mice

Hydrogen-rich Water Partially Alleviate Inflammation, Oxidative Stress and Intestinal Flora Dysbiosis in DSS-induced Chronic Ulcerative Colitis Mice

Anti-inflammatory and anti-oxidant properties of Melianodiol on DSS-induced ulcerative colitis in mice

Lactobacillus fermentum ZS40 Ameliorates Inflammation in Mice With Ulcerative Colitis Induced by Dextran Sulfate Sodium

Saccharomyces boulardii Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-κB and Nrf2 Signaling Pathways

Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis.

[Sanguinarine alleviates ulcerative colitis in mice by regulating the Nrf2/NF-κB pathway]

Protective effect of soluble dietary fiber from Rosa roxburghii Tratt residue on dextran sulfate sodium-induced ulcerative colitis by regulating serum metabolism and NF-κB pathway in mice